You are here

Fortress Biotech

A snakebit biotech receives second CRL for reformulated pain med

Endpoints

Mon, 06/14/21 - 10:26 am

Avenue Therapeutics

Fortress Biotech

post-operative pain

The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More

Yahoo/Benzinga

Mon, 12/2/19 - 09:42 am

Bristol-Myers Squibb

Acadia Pharmaceuticals

Cassava Sciences

Magenta Therapeutics

Fortress Biotech

Alexion Strikes Development Deal With Caelum Biosciences in Rare Systemic Disorder

BioSpace

Thu, 01/31/19 - 11:18 am

Alexion Pharmaceuticals

Fortress Biotech

Caelum Biosciences

light chain amyloidosis

Special Report: Biotech incubator taps investors through in-house brokerage

Reuters

Fri, 08/3/18 - 09:39 am

Avenue Therapeutics

Checkpoint Pharmaceuticals

Fortress Biotech

Fortress Bio soars after reporting breakthrough with CAR-T cancer approach

Marketwatch

Thu, 12/29/16 - 10:22 am

Fortress Biotech

Fortress Biotech Presents Positive Data from the Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia

Yahoo

Wed, 05/18/16 - 11:18 am

Fortress Biotech

clinical trials

acute myeloid leukemia